Fullife Healthcare's growth with wellness product innovation.
D2C health and wellness startup Fullife Healthcare, known for its brands Fast&Up and Chicnutrix, has secured ₹300 Cr (approximately $32 million) in a Series D funding round. Elev8 Venture Partners led the investment.
The capital will support the expansion of Fullife’s brands, including Fast&Up, Chicnutrix, and NightOut, focusing on dietary supplements and effervescent tablet offerings. Fast&Up offers effervescent tablets for weight loss, nutrition, hydration, and energy, and has expanded into protein and pre-workout supplements. Chicnutrix provides skincare products such as serums, face masks, and glutathione and keratin effervescent tablets.
Fullife, founded in 2011 by Varun Khanna, offers over 100 SKUs across hydration, metabolic health, sports nutrition, and beauty wellness. The company plans to expand into digestive health, sleep support, and protein-based nutrition. Prior to this round, Fullife raised over $30 million from investors including Six Sense Ventures and Kotak Securities, with Morgan Stanley Private Equity Asia (MSPEA) leading a $22 million Series C raise in 2021. Celebrity investors Shilpa Shetty and Varun Dhawan also back the company.
Fullife’s brands are present in over 40 countries, with expansion in the US, Europe, and Gulf regions. The company operates a manufacturing facility in Maharashtra and partners with foreign pharmaceutical companies for product development. Plans include scaling manufacturing and distribution, deepening retail presence, enhancing digital access, and investing in new delivery formats and product innovation.
Fullife competes with brands like Plix, Wellbeing Nutrition, and Oziva in the effervescent tablet market. Legacy brands are also entering the nutraceuticals space, with Dabur launching Siens and Marico acquiring a majority stake in Plix. USV recently acquired a 79% stake in Wellbeing Nutrition for ₹1,583 Cr ($174.7 million).
About the Author
